Guruduth Banavar

Eli Lilly and Company expands Welldoc partnership to use AI and extend its reach across the patient journey >> 💊 Lilly has expanded its partnership with Welldoc to launch the new Lilly Health app for patients prescribed Zepbound (for weight loss) or Mounjaro (for diabetes) 💊 The app provides medication reminders, dose logging with visual progress, and syncs with compatible health devices to track data like weight, glucose, and activity 💊 Built on Welldoc’s FDA-cleared cardiometabolic platform, the app is free to use and offers AI-driven insights, nutrition and exercise tools, and trend tracking to support long-term health management 💊 The platform aims to enhance care coordination between patients and providers for complex cardiometabolic conditions, including obesity, diabetes, and even sleep apnea 💊The expanded partnership builds on Lilly’s 2021 integration of Welldoc into its Tempo system, reflecting a broader push to create a more seamless, connected, and personalized experience for patients on its incretin therapies #digitalhealth #ai #pharma

163

11 Comments

Aditya Narayan and I are proud to share a Health Affairs Scholar piece on CMMI's new ACCESS payment model. ACCESS will pay for care delivered by AI (with or without a clinician) for Medicare patients. This is the first time ever Medicare will pay for care without a person in the loop. It is for chronic-disease management: recurring, condition-specific payments tied to clinical improvement, rather than billing for discrete encounters or tightly defined remote-monitoring activities. The promise is straightforward, more reimbursement for technology-enabled longitudinal care and more choice and competition for patient care. It could lead to lots of startup and innovation. It could also lead to lots of hard to cancel subscriptions and FWA. There are still many unanswered questions about payment levels, how quality is measured, how risk is adjusted, and how these patients’ facing technology enabled services will coordinate care with the traditional delivery systems. https://lnkd.in/grDfXDH5

148

23 Comments

"Clarity in the midst of Chaos" - what an apt summary of the India AI Impact Summit 2026 by Dr Bhaskar Rajakumar Those who could not be at the India AI Impact Summit - this is a good summary of the direction, path and snippets from the iconic summit. 👇 👇 👇

26

1 Comment

Proud to share that our VALID Framework—the industry's first comprehensive approach to evaluating AI-extracted real-world data—is now published in American Society of Clinical Oncology (ASCO) ‘s JCO CCI. When I think about Flatiron's vision to unlock the power of real-world data at scale, this framework embodies what responsible innovation looks like. It's not about moving fast at the expense of rigor. It's about moving fast with rigor. This work represents the best of Flatiron: brilliant scientists, clinicians, and engineers committed to building tools that researchers, clinicians, and patients can trust. Thank you to everyone who contributed—from research to engineering to clinical leadership. Read more: https://lnkd.in/g58g9xup

51

2 Comments

The interviewer of this episode was more impressive than the one who was interviewed but I enjoyed it! Every health system should challenge providers with real-time cost data inside a clinical, evidence-based context. “We’ve built alerts” or “made it hard to order that” is not changing a culture! Cultures change when approaches iterate and alignment models promote and support the change.

10

1 Comment